VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hyo Jae Kim
Boryung Pharmaceutical Co., Ltd
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Soonchunhyang University Bucheon Hospital
Bucheon-si, South Korea
- Inje University Haeundae Paik Hospital
Busan, South Korea
- Kosin University Gospel Hospital
Busan, South Korea
- Pusan National University Hospital
Busan, South Korea
- Keimyung University Hospital(dongsan Medical Center)
Daegu, South Korea
- Yeungnam University Medical Center
Daegu, South Korea
- Chungnam National University Hospital
Daejeon, South Korea
- National Cancer Center
Goyang, South Korea
- Gyeongsang National University Changwon Hospital
Gyeongsang, South Korea
- Chonnam National University Hwasun Hospital
Hwasun, South Korea
- Gachon University Gil Medical Center
Incheon, South Korea
- Dankook University Hospital
Jungnam, South Korea
- Chung-Ang University Hospital
Seoul, South Korea
- Kangbuk Samsung Hospital
Seoul, South Korea
- Korea University Anam Hospital
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Severance Hospital
Seoul, South Korea
- Soonchunhyang University Hospital
Seoul, South Korea
- the Catholic University of Korea, Seoul St. Mary'S Hospital
Seoul, South Korea
- Ajou University Medical Center
Suwon, South Korea
- Chungbuk National University Hospital
Taebuk, South Korea
- Ulsan University Hospital
Ulsan, South Korea
- Wonju Severance Christian Hospital
Wŏnju, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Nov 2018
- Primary completion
- 11 Jan 2023
- Completion
- 11 Jan 2023
- Last update posted
- 15 Jun 2023
- Registered enrollment
- 203
- Registry id
- NCT04151615
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.